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Abstract
Background: Sox10, a member of the Sry-related HMG-Box gene family, is a critical transcription
factor for several important cell lineages, most notably the neural crest stem cells and the derivative
peripheral glial cells and melanocytes. Thus far, only a handful of direct target genes are known for
this transcription factor limiting our understanding of the biological network it governs.
Results: We describe identification of multiple direct regulatory target genes of Sox10 through a
procedure based on function and conservation. By combining RNA interference technique and
DNA microarray technology, we have identified a set of genes that show significant down-
regulation upon introduction of Sox10 specific siRNA into Schwannoma cells. Subsequent
comparative genomics analyses led to potential binding sites for Sox10 protein conserved across
several mammalian species within the genomic region proximal to these genes. Multiple sites
belonging to 4 different genes (proteolipid protein, Sox10, extracellular superoxide dismutase, and
pleiotrophin) were shown to directly interact with Sox10 by chromatin immunoprecipitation assay.
We further confirmed the direct regulation through the identified cis-element for one of the genes,
extracellular superoxide dismutase, using electrophoretic mobility shift assay and reporter assay.
Conclusion: In sum, the process of combining differential expression profiling and comparative
genomics successfully led to further defining the role of Sox10, a critical transcription factor for the
development of peripheral glia. Our strategy utilizing relatively accessible techniques and tools
should be applicable to studying the function of other transcription factors.
Background
Identifying direct targets of a given transcription factor is
a key step in dissecting the regulatory network wherein the
detailed function of the transcription factor can be under-
stood. Early attempts included ectopic over-expression
followed by expression profiling for identification of can-
didate genes which in turn entailed extensive sequence
analyses of the promoter region [1]. Another strategy was
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direct cloning of DNA fragments associated with tran-
scription factors which also entailed extensive sequence
analyses for identification of nearby genes [2].
Several recently developed molecular tools and technical
advances have been paving ways for achieving the same
goal in a more efficient high throughput manner. For
example, microarray expression profiling has dramatically
improved the differential screening, and completion of
genome sequencing for several species now allows a rapid
identification of genes in the genomic context as well as
the application of comparative genomics analysis for con-
served DNA elements. Furthermore, RNA interference
(RNAi) revolutionized somatic cell genetics making it
possible to perform loss-of-function experiments conven-
iently while chromatin immunoprecipitation (ChIP)
assay provides a reasonably efficient means of testing
direct interaction between proteins and DNA within cellu-
lar context. It had been envisioned that these tools, in var-
iable combinations [3,4], can be utilized for identifying
direct regulatory targets of transcription factors, and suc-
cessful cases are being reported [5,6].
Sox10 is an HMG box family transcription factor
expressed in neural crest stem cells and a subset of neural
crest derived lineages [7-9]. At the stem cell stage, Sox10
plays the role of a stem cell factor maintaining multipo-
tency and inhibiting premature neurogenesis [8]. In glial
cells of the peripheral nervous system (PNS) and melano-
cytes, Sox10 continues to be expressed after their lineage
segregation and promotes differentiation by targeting cell
type specific genes [10]. The function of Sox10 has been
extensively studied in vivo with gene-targeted and sponta-
neously occurring mutant murine models [7,11,12]. Het-
erozygous and homozygous loss-of-function mutations of
Sox10 result in severe compromises in the development of
PNS via glial developmental failure as well as in the pro-
liferation and differentiation of melanocytic lineages. The
human patients of Waardenburg-Shah syndrome with
mutations in Sox10 show strikingly similar phenotypes to
heterozygous mutant murine models typified by megaco-
lon and hypopigmentation [13].
To date, only a handful of direct regulatory targets of
Sox10 are known. In the glial lineage, genes such as the
P0, myelin basic protein (MBP), ciliary neurotrophic fac-
tor (CNTF) and connexin 32 (Cx32) have been shown to
be direct targets of Sox10 [14-17]. In melanocytes, Sox10
has been shown to directly regulate at least two genes,
microopthalmia (MITF) and dopachrome tautomerase
(DCT) [18-20]. It is likely that Sox10 has additional direct
target genes in both glial and melanocytic cells during dif-
ferentiation and in mature stage.
Here, we describe a stream-lined procedure in identifying
such direct regulatory targets. We took advantage of RNAi
technique to screen for genes in a Schwannoma cell line
that are down-regulated upon introducing small interfer-
ing RNA (siRNA) specific for Sox10. Genes with signifi-
cant level of down-regulation were subjected to
comparative genomics analysis for identification of
potential Sox10 binding sites that are conserved in multi-
ple mammalian species. Next, we confirmed the physical
interaction between Sox10 and the predicted target bind-
ing sites by chromatin immunoprecipitation (ChIP) assay
leading to identification of at least 4 novel direct regula-
tory targets, proteolipid protein (PLP), Sox10, extracellu-
lar superoxide dismutase (SOD3), and pleiotrophin
(Ptn). We further confirm the direct regulation of SOD3
by Sox 10 through the identified cis-element using electro-
phoretic mobility shift assay (EMSA) and reporter assay.
Results
We have previously reported a case of apparent transdif-
ferentiation of RT4D6 Schwannoma cells into smooth
muscle cells upon introduction of an siRNA specific to the
transcription factor Sox10 [21]. Accompanying gene
expression profiling showed apparent down-regulation of
several glial specific marker genes such as GFAP and p75
and up-regulation of smooth muscle specific genes
including  α-smooth muscle actin confirming the phe-
nomenon of transdifferentiation. Sox10 is known to be a
direct transcriptional activator of genes specific to glial lin-
eage including P0 and MBP [16,17]. We reasoned that sev-
eral of the genes down-regulated by Sox10 specific siRNA
are likely to represent additional direct regulatory targets.
We further reasoned that such direct regulatory targets
have appropriate cis-elements, Sox10 protein binding
sites that are conserved across mammalian if not verte-
brate species.
Gene expression profiling was carried out with two inde-
pendent pairs of RT4D6 cell samples each treated with
wild type and mutant siRNAs, and 88 affy probes that
showed at least 4-fold down-regulation upon introduc-
tion of Sox10 specific siRNA were identified (see Methods;
additional data file 1). Among these, 44 genes had RefSeq
Ids and were subjected to subsequent promoter and com-
parative genomics analyses (additional data file 1). We
examined the genomic region of each gene from -2 kb
upstream of the transcription start site to the end of the
first intron to identify the conserved potential Sox10
binding sites. Although systematic analyses for preferred
binding sites have been carried out for several Sox pro-
teins, no such study has been reported for Sox10 [22-25].
In addition, these sites have been determined through in
vitro binding assays which may not fully reflect the in vivo
binding preference or potential. We therefore took as the
core element the 5 nucleotide sequence, 5'ACAAT3' (or
the complementary sequence 5'ATTGT3'), that is targeted
by all tested Sox proteins. From the rat genomic sequencesBMC Genomics 2008, 9:408 http://www.biomedcentral.com/1471-2164/9/408
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examined, profile search using the TRANSFAC database
led to the identification of 1328 sites.
We next applied the cross-species conservation criteria
(see Methods) reasoning that functional Sox10 binding
sites are likely conserved across mammalian species. This
led to further refinement of putative targets to 95 candi-
date sites belonging to 24 genes (additional data file 2).
For the subsequent validation analyses using 'wet-lab'
experimental procedures, further selection was carried
out. Specifically, only the genes which showed 6-fold or
higher levels of change by specific siRNA and whose core
elements were perfectly conserved among all mammalian
species with accessible genome were selected. This led to
the final 10 genes with 23 putative SOX10 binding sites
(table 1). The computational pipeline is summarized in
figure 1, and figure 2 shows the gene structure, conserved
genomic regions, and nucleotide sequence surrounding
the putative binding site of one of the 10 genes, SOD3.
We next sought to confirm the regulatory relationship
between Sox10 and the proposed 10 target genes. cDNA
preparations were made from RT4D6 cells treated with
Sox10 specific and control siRNAs. Real time PCR analy-
ses showed that all the proposed 10 target genes were
clearly down-regulated as the result of Sox10 down-regu-
lation confirming the microarray screen results (figure 3).
Chromatin immunoprecipitation assay was performed for
the 23 putative Sox10 binding sites (table 1) with RT4D6
cells transfected with a Flag epitope tagged Sox10 con-
struct. Ectopic expression of epitope tagged Sox10 was
necessary due to the absence of an antibody that effec-
tively immunoprecipitated the endogenous Sox10 from
RT4D6 cells. As some of the potential binding sites were
located close to one another, only 17 pairs of primer were
used to examine the 23 sites. As a control, each of the sites
was examined after precipitation with IgG antibody. We
also used β-actin locus and a cis-locus located 10 kb away
from the putative Sox10 binding site of SOD3 gene as
additional negative controls. The result suggests that at
least 4 genes, PLP, Sox10, SOD3, and Ptn contain binding
sites that SOX10 interacts with clearly detectable affinity,
and Ngfr and Cmkor1 may represent additional Sox10
target genes (figure 4).
We chose SOD3 for further validation as the direct regula-
tory target of Sox10. The unique candidate binding site,
conveniently located in the 5' enhancer region, shows a
perfect conservation between rat, mouse, human, dog,
and opossum (figure 2).
We first confirmed that Sox10 protein can bind to the can-
didate site by EMSA (figure 5). The DNA binding domain
of Sox10 readily formed a protein-DNA complex with a
probe spanning the candidate binding element. Impor-
tantly, the binding between the protein and the labeled
probe was effectively abrogated by specific unlabeled
probe but not by non-specific probe which contains
mutations in the core SOX binding sequence.
Table 1: The candidate 10 genes and 23 putative Sox10 binding sites tested by ChIP assay.
gene symbol RefSeq ID target cis element chromosome start end Location primer pair #
Cmkor1 NM_053352 tttATTGTtctc 9 89344237 89344250 Intron 1
agcACAATgg 9 89346538 89346547 Intron 2
Gda NM_031776 ttgACAATtt 1 224640748 224640757 Intron 3
PLP NM_030990 cctATTGTgttt X 124488088 124488101 5'enhancer 4
taATTGTttt X 124492945 124492954 intron 5
ctATTGTata X 124493179 124493188 Intron 6
gaATTGTgtg X 124493238 124493247 Intron 6
ggtACAATtg X 124493249 124493258 Intron 6
ccATTGTtta X 124494810 124494819 Intron 7
Sox10 NM_019193 agATTGTcca 7 117150489 117150498 5'enhancer 8
caATTGTctg 7 117150400 117150409 5'enhancer 8
SOD3 NM_012880 ccATTGTgcc 14 63387776 63387785 5'enhancer 9
Erbb3 NM_017218 tcATTGTggg 7 1874401 1874410 Intron 10
gacACAATag 7 1874335 1874344 Intron 10
Ptn NM_017066 caATTGTtgg 4 64147810 64147819 Intron 11
cacACAATag 4 64147702 64147711 Intron 11
taATTGTgag 4 64136510 64136519 Intron 12
atATTGTaac 4 64127690 64127699 Intron 13
attACAATaa 4 64126376 64126385 Intron 14
Ngfr NM_012610 tggACAATgg 10 84280255 84280264 Intron 15
cagACAATgg 10 84280237 84280246 Intron 15
Gzmb NM_138517 cgATTGTgat 15 35199893 35199902 5'enhancer 16
Gas7 NM_053484 ccATTGTatg 10 54304002 54304011 Intron 17
The number in the last column indicates the primer pair used to test each site by ChIP assay (see additional data file 3).BMC Genomics 2008, 9:408 http://www.biomedcentral.com/1471-2164/9/408
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Next, we examined the role of the candidate binding site
in a reporter assay (figure 6). Two reporter constructs were
designed. The wild type SOD3 reporter, pGL3-SOD3, has
luciferase gene ligated to the 5' enhancer and UTR region
of SOD3 inclusive of the candidate cis-element while
mutant promoter pGL3-SOD3-mut is identically designed
except for mutations in the core SOX binding element.
These reporter plasmids were co-transfected with various
combinations of wild type and mutant siRNAs for Sox10.
Importantly, at all concentrations of the wild type siRNA,
the wild type reporter showed consistently higher activity
than the mutant reporter demonstrating the importance
of the intact core Sox binding element. The activity of the
wild type reporter showed a concentration dependent
down-regulation by the wild type siRNA while the mutant
reporter showed little variation of the low level activity.
Taken together with the results from ChIP assay and
EMSA, these data demonstrate that SOD3 is a direct regu-
latory target of Sox10 which imparts its activity through
the conserved Sox binding element in the 5' enhancer
region.
Discussion
We have applied in combination several recently devel-
oped techniques and tools of molecular biology to iden-
tify multiple novel targets of Sox10. Rather than relying
on overexpression of Sox10, we used RNAi to screen for
affected genes. Overexpression of transcription factors can
potentially activate non-physiological targets or even
repress true targets by 'squelching'. Overexpression of
transcription factors in cells already expressing the factor
may also have minimal or no effects on the level of target
Overview of the study Figure 1
Overview of the study. The study is composed of three main stages. First, the microarray data analysis resulted in 44 signifi-
cantly down-regulated candidate genes from the siRNA knock down experiment. The second stage process, the promoter 
analysis, led to the identification of 23 conserved putative Sox10 binding sites belonging to 10 genes. The last stage process 
includes various wet-lab validation experiments.BMC Genomics 2008, 9:408 http://www.biomedcentral.com/1471-2164/9/408
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gene expression. The loss-of-function approach followed
by microarray screen should produce less non-specific
side effects and thus lead to more precise profiling of
direct and indirect targets. The procedure combining dif-
ferential expression profiling and comparative genomics
analyses represents a reasonably streamlined method
accessible for most molecular biology laboratories.
There are clearly more direct target genes for Sox10 than
those we have identified here. The number is limited due
to several practical reasons. Most importantly, in the end
we have examined by 'wet-lab' experiments only the genes
that showed at least 6-fold decrease upon down-regula-
tion of Sox10. This excludes the far greater number of
genes that are less but meaningfully affected by the change
in the level of Sox10. Furthermore, we have restricted our
search within the span of -2 kb from the transcription ini-
tiation site to the end of the 1st intron. It is well established
that regulatory cis-elements often reside outside such
span. Lastly, applying less stringent requirements for the
core element sequence and the degree of conservation
should allow identification of additional candidate tar-
gets. It should also be noted that Sox10 plays important
roles in other cell types than Schwann cells. These include
neural crest stem cells, melanocytes, and oligodendro-
cytes. Given that Sox10 likely regulates different genes in
different cellular contexts, we should expect distinct addi-
tional direct targets of Sox10 from these cells. An impor-
tant merit to our method is that all these limiting
parameters can be easily adjusted for expanded search.
Obviously, more comprehensive procedures such as
ChIP-on-chip or ChIP-Seq screening would produce more
direct targets. However, these methods also have inherent
limitations and shortcomings and cannot be readily
applied to all cases, and developing diverse strategies to
identifying targets of transcription factors will continue to
be important. An inherent requirement for identifying
direct targets of transcription factors is proving through
biological functional assays. It should be noted that it is
thus difficult to assess the error rates during each of the fil-
A. SOD3 locus on rat chromosome 14; adapted from the University of California at Santa Cruz (UCSC) Genome Browser Figure 2
A. SOD3 locus on rat chromosome 14; adapted from the University of California at Santa Cruz (UCSC) Genome Browser. 
The conserved cluster shown in the Conservation track containing the putative SOX10 TFBS is indicated by the red box near 
the right end of the panel. The unique site detected by V$SOX9_01 and V$SOX5_01 matrices in the TRANSFAC database is 
also indicated in the box. B. The nucleotide sequences surrounding conserved binding site is shown in detail. The numbers in 
the parentheses in the Position track indicate the distance from the SOD3 transcription start site. The red box indicates the 
conserved core sequence, 5'ACAAT3'.BMC Genomics 2008, 9:408 http://www.biomedcentral.com/1471-2164/9/408
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tering steps. If and when extensive biological data are col-
lected, a retrospective assessment of the accuracy of
prediction from each criterion may be possible. In a sense,
our goal in the current study can be described as an appli-
cation of data exploration techniques to objectively and
subjectively identify the genes most likely to yield positive
results in our biological assays of binding and transcrip-
tional activation.
We propose four novel direct targets of Sox10. PLP expres-
sion has been shown to be rapidly and robustly induced
by Sox10 in Tet-inducible Neuro2A cells [26], and PLP is
also known to be expressed in Schwann cells [27,28].
Sox10 has been shown to directly regulate other myelin
genes including MBP and Cx32 [14,17], and our identifi-
cation of PLP as another target is consistent with the role
that Sox10 plays in peripheral glial cells. Pleiotrophin is a
heparin binding secreted soluble factor with multiple
functions in various systems [29,30]. Of note it is
expressed in glial cells of CNS and PNS during develop-
ment as well as in adult stages [29,30]. Its up-regulation in
Schwann cells after nerve resection also suggest a role in
axon regeneration, a process requiring active participation
of Schwann cells [31]. SOD3 is the extracellular form of
superoxide dismutase that functions as the major extracel-
lular scavenger of superoxide [32]. SOD3 gene-targeted
Down-regulation of Sox10 by wild type siRNA results in  down-regulation of the 10 target genes Figure 3
Down-regulation of Sox10 by wild type siRNA results in 
down-regulation of the 10 target genes. Real time PCR was 
performed on cDNA preparations from RT4D6 cells trans-
fected with wild type and mutant Sox10 siRNAs. The values 
shown are the relative ratios of expression level normalized 
with GAPDH expression level. Data are the average of three 
independent experiments each with two measurements, and 
error bars represent standard deviations.
ChIP assay Figure 4
ChIP assay. Chromatin immunoprecipitation was carried out 
in RT4D6 cells transfected with pFlag-Sox10. Values from 
immunoprecipitation with anti-Flag antibody represent the 
fold difference relative to those from IgG control antibody. 
Number in the parentheses next to the gene name indicates 
the primer pair used (see table 1 and additional data file 3). 
Data are the average of three independent experiments each 
with two measurements, and error bars represent standard 
deviations.
EMSA Figure 5
EMSA. EMSA was performed with a 32P end-labeled SOD3 
probe containing the conserved Sox binding site. Proteins 
added are noted at the top. The upper arrowhead indicates 
the GST-SOX10 HMG/DNA probe complex, and the lower 
arrowhead indicates the free probe. For competition experi-
ments, unlabeled wild type (WT) or mutated (MT) probes 
were added to the indicated excess levels.BMC Genomics 2008, 9:408 http://www.biomedcentral.com/1471-2164/9/408
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mouse does not show clear phenotypes except for the
reduced viability under hyperoxic condition [32]. Never-
theless, under various experimental conditions, the pro-
tective role of SOD3 on neural tissues has been shown
suggesting that secreted SOD3 may play a role in reducing
oxidative stress to neurons and Schwann cells [33,34].
That Sox10 was among the down-regulated genes was not
necessarily meaningful given that Sox10 specific siRNA
had been applied to the cell. Still, results from the ChIP
assay indicate that Sox10 may regulate its own expression.
Whether an active positive feedback loop contributes to
known functions of Sox10 such as promoting and main-
taining glial phenotype should be further explored. While
Ngfr (p75) is a well established marker of Schwann cell
[8], the expression and function of Cmkor1, chemokine
orphan receptor 1 (also known as CXCR7), in Schwann
cell lineage have not been investigated thus far. Binding of
Sox10 to the putative Sox binding elements belonging to
these genes is repeatable, and given the change in the
expression level upon down-regulation of Sox10, we
would tentatively classify these genes as direct regulatory
targets of Sox10. Additional characterization of their bind-
ing elements through mutation analyses and reporter
assays should further validate the assignment.
Conclusion
We have developed and successfully applied a streamlined
procedure for identification of direct targets of the tran-
scription factor Sox10. The key elements are RNAi based
expression profiling and comparative genomics analysis
which led to prediction of candidate cis-elements belong-
ing to multiple candidate genes. We subsequently con-
firmed direct interaction between several of these
candidate cis-elements and Sox10 and identified at least 4
different genes as direct regulatory targets of Sox10. Our
methodology should be applicable to other transcription
factors, and genes thus discovered should be useful in
deciphering physiology and function of peripheral glial
cells which are critically dependent on Sox10.
Methods
Microarray expression profiling
Duplicate expression profiles were obtained with the
GeneChip Rat 230 2.0 Array from the Affymetrix Co as has
been described [21]. The microarray data have been
deposited in the Gene Express Omnibus (GEO) database
[GEO:GSE12007]. We subsequently used the GeneSpring
GX7.3 for the data analysis. As a pre-filtering step, only the
genes classified in "present" or "marginal" categories in
both of the duplicate screens with the mutant (control)
siRNA were selected in order to include only those genes
with detectable level of expression in the absence of inhi-
bition of Sox10. After median normalization, we selected
881 genes that were down-regulated by the wild type (spe-
cific) siRNA by more than 2-fold. We next used a t-test sta-
tistics to produce 363 differentially expressed genes at the
p-value of 0.05. No multiple test correction was applied.
Further reduction in the number of candidate genes for
subsequent examination was achieved by increasing the
threshold to 4-fold reduction which yielded a set of 88
affy probes (additional data file 1). Subsequently, we
manually examined the genomic regions specified by the
affy probes to select only the genes with RefSeq ID. The 44
genes thus obtained (additional data file 1) were sub-
jected to comparative genomics analysis for the presence
of conserved potential Sox10 binding sites.
Computational identification of the putative Sox binding 
sites
We developed a computational pipeline that combined
the promoter analysis and the comparative genomics
analysis. Genomic sequence from the upstream 2 kb point
Reporter assay Figure 6
Reporter assay. A. The reporter constructs are illustrated. 
pGL3-SOD3 contains the wild type SOD3 enhancer 
sequence while pGL3-SOD3-mut is identical except for the 
mutations in the core SOX binding element. These are 
derived from pGL3-basic shown at the top. B. Normalized 
relative levels of luciferase activity are shown with the value 
from pGL3-SOD3 in the absence of wild type siRNA as 
100%. The combined amount of wild type and mutant siR-
NAs was equal in all cases. Data are the average of three 
independent experiments, and error bars represent standard 
deviations.BMC Genomics 2008, 9:408 http://www.biomedcentral.com/1471-2164/9/408
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with respect to the transcription start site to the end of the
first intron was extracted from the rat genome assembly
version 3.4 (Nov. 2004 version in the UCSC genome
browser) for the 44 genes. The MATCH program [35] in
the TRANSFAC®  Professional 10.2 http://www.biobase-
international.com/[36] was used to perform the profile
search for the transcription factor binding sites (TFBS).
The vertebrate binding matrices and the only high quality
matrix option were used in the profile selection, and the
cut-offs for core and matrix similarity were set to 0.9999
and 0.7 respectively without any change in the other
options. The matrix identifiers V$SOX5_01 and
V$SOX9_B1 were selected among the several available
Sox binding matrices in the TRANSFAC database [22,25].
As the core element, we used 5'ACAAT3' or its comple-
ment sequence. Profile search with these two matrices
resulted in 1328 putative SOX binding sites which were
mapped back to the rat genome assembly. All these proce-
dure were automated by our own browser-emulating Perl
program for batch processing.
We next set up a filtering step utilizing the cross-species
conservation information. The phastCons score database
[37] of 9 species (rat, mouse, human, dog, cow, opossum,
chicken, frog, and zebrafish) conservation was down-
loaded from the UCSC genome browser [38]. The data-
base contains two columns one of which lists genomic
coordinates (i.e. base pair position) and the other the cor-
responding phastCons scores indicating the posterior
probability of conservation in a scale of 0 to 1. The con-
servation score for each TFBS was evaluated to be the aver-
age phastCons score within the TFBS region. Setting the
conservation cut-off to 0.7, we obtained the final 95 puta-
tive Sox binding sites proximal to 24 independent genes
(additional data file 2).
For subsequent examination by chromatin immunopre-
cipitation (ChIP) assay, only the genes with 6-fold or
higher level of change from the microarray screen were
considered. The identified TFBS were visually inspected
for 100% sequence conservation of the core sequence in
human, mouse, rat, and dog, and 23 different putative Sox
binding sites in 10 genes were finally selected for ChIP
assay. The name of the genes and genomic locations for
the candidate TFBS are listed in the table 1.
Recombinant Sox10 constructs for EMSA and ChIP assay
For the production of GST fusion protein, HMG domain
of Sox10 (a.a. 80~185) was PCR amplified from a mouse
cDNA clone and inserted into pGEX-4T-1 plasmid vector
(Amersham). The sequences of primers used were 5'-
AGAATTCCTCAGCGGCTACGACTGGACG-3' and 5'-
ACTCGAGCTGGGCTGCCTTCCCGTTC-3' [9]. The E. coli
strain BL21 was transformed with the construct, and pro-
tein was purified using glutathione agarose beads after
IPTG induction.
pFlag-Sox10 was generated by PCR amplifying the full
length Sox10 with a pair of PCR primers, 5'-AGCG-
GCCGCGCCGAGGAACAAGACCTATC-3' and 5'-AGTC-
GACCTCTAAGGTCGGGATAGAGTCG-3' and inserting
the product into pFLAG-CMV vector (Invitrogen) in frame
with the FLAG epitope.
Chromatin immunoprecipitation (ChIP) assay
For the ChIP assay, 2 μg of pFlag-Sox10 plasmid was
transfected into 5 × 105 RT4D6 cells on a 100 mm dish
using Effectene transfection reagent (Qiagen). Typically,
cells pooled from 4 plates (2 × 106 cells) were processed
per assay. ChIP assays were performed using EZ ChIP™
Chromatin immunoprecipitation kits (Upstate) following
the manufacturer's protocols except for the elution of pro-
tein-DNA complex. Specifically, immunoprecipitated
DNA-protein complexes were eluted twice by adding 100
μl elution buffer containing 3× FLAG peptide (Sigma; 150
ng/μl of 3× FLAG peptide, 50 mM Tris-HCl, pH 7.4, 150
mM NaCl) for 30 min at 4°C. Detailed protocols are avail-
able upon request. For the 23 potential Sox10 binding
sites subjected to ChIP assay, only 17 PCR primer pairs
were used as cis-elements within 200 bp were examined
with the same primer pairs. Primer pairs used for PCR are
listed in the additional data file 3.
Electrophoretic mobility shift assay (EMSA)
A pair of oligonucleotides (5'-GAAGAGGCACAAT-
GGTCTCT-3'; 5'-ACCATTGTGCCTCTTC-3') encompass-
ing the candidate SOX10 binding sequence (-590 to -610
5' to the transcription initiation site of SOD3) were
hybridized and 32P end-labeled for use as the probe. Unla-
beled oligonucleotide probe and core sequence mutated
oligonucleotide probe (5'-GAAGAGGCAGACT-
GGTCTCT-3'; 5'-AGAGACCAGTCTGCCTCTTC-3') were
used as the specific and non-specific competitors respec-
tively.  32P end-labeled probe was incubated with GST-
SOX10 HMG protein for 25 min at room temperature in
35 μl of reaction mixture [10 mM HEPES (pH 8.0), 5%
glycerol, 50 mM NaCl, 5 mM MgCl2, 2 mM DTT, 0.1 mM
EDTA, 4 μg of bovine serum albumin, and 2 μg of
poly(dIdC)]. For competition experiments, GST-SOX10
HMG protein was preincubated with specified amount of
unlabeled probe for 15 min before exposure to the labeled
specific probe. The protein-DNA complexes were resolved
by 5% polyacrylamide gel electrophoresis in 1× TBE
buffer.
Real Time PCR
Fluorescence real time PCR was performed with SYBR
Green PCR master mix (Applied Biosystems) following
the manufacturer's protocol. Oligonucleotide primersBMC Genomics 2008, 9:408 http://www.biomedcentral.com/1471-2164/9/408
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used as part of the ChIP assay are listed in additional data
file 3, and primers used to confirm the microarray screen
data are listed in additional data file 4. Preparation of
cDNA from siRNA treated RT4D6 Schwannoma cells has
been described [21].
Reporter assay
The promoter region of SOD3 (-739 to +76) was PCR
amplified with a pair of primers (5'-ACAGGACAGAC-
CCAGCTAGAG-3', 5'-ACCACAGTCCTGGAGAGAGTG-
3') using the BAC clone CH230-303F11 (Children's Hos-
pital Oakland Research Institute) as the template. The
resulting DNA fragment was inserted into the 5' region of
pGL3 basic promoter (Promega) to produce the wild type
reporter construct. The reporter construct with mutated
Sox10 binding site was generated using QuickChangeII
Site-directed Mutagenesis Kit and a pair of mutagenizing
oligonucleotide primers (5'-GTTTGAAGAGGCAGACT-
GGTCTCTTTATTG-3', 5'-CAATAAAGAGACCAGTCT-
GCCTCTTCAAAC-3'). For reporter assays, 3 × 104 RT4D6
cells were seeded on 12 well plates 24 hours prior to trans-
fection. SOD3 reporter plasmids (300 ng), pCMV β-gal
plasmids (50 ng), and specified combinations of wild
type and mutant siRNAs (combined concentration of 100
nM) were transfected using Lipofectamine 2000 (Invitro-
gen). After 24 hours, cells were harvested and luciferase
activity was measured and normalized using Luciferase
Assay System (Promega)
Authors' contributions
KL carried out the ChIP assay and contributed to prepar-
ing the manuscript. SN carried out bioinformatics analy-
ses. EC carried out the RTPCR and reporter assay. IS
carried out the EMSA. JL organized the data and contrib-
uted to preparing the manuscript. SL designed the bioin-
formatics analyses and drafted the manuscript. JK
designed the 'wet-lab' experiments and drafted the manu-
script.
Additional material
Acknowledgements
This research was supported by a grant to JK (M103KV010007-06K2201-
00710) from Brain Research Center of the 21st Century Frontier Research 
Program funded by the Ministry of Education, Science and Technology, by 
grant No. R15-2006-020 from the National Core Research Center 
(NCRC) program of the Ministry of Education, Science & Technology 
(MEST) and the Korea Science and Engineering Foundation(KOSEF) 
through the Center for Cell Signaling & Drug Discovery Research at Ewha 
Womans University, by a grant to Ewha Research Center for Systems Biol-
ogy (ERCSB) from Systems Biology Research Project of Gwangju Institute 
of Science & Technology (GIST), and by the Korea Research Foundation 
Grant funded by the Korean Government (MOEHRD) (KRF-2005-041-
C00345) to JK. KL and EC were supported by fellowships from Brain Korea 
21 Project.
References
1. Hermeking H, Rago C, Schuhmacher M, Li Q, Barrett JF, Obaya AJ,
O'Connell BC, Mateyak MK, Tam W, Kohlhuber F, et al.: Identifica-
tion of CDK4 as a target of c-MYC.  Proc Natl Acad Sci USA 2000,
97:2229-2234.
2. Solano PJ, Mugat B, Martin D, Girard F, Huibant JM, Ferraz C, Jacq B,
Demaille J, Maschat F: Genome-wide identification of in vivo
Drosophila Engrailed-binding DNA fragments and related
target genes.  Development 2003, 130:1243-1254.
3. Kirmizis A, Farnham PJ: Genomic approaches that aid in the
identification of transcription factor target genes.  Exp Biol
Med (Maywood) 2004, 229:705-721.
4. Nardone J, Lee DU, Ansel KM, Rao A: Bioinformatics for the
'bench biologist': how to find regulatory regions in genomic
DNA.  Nat Immunol 2004, 5:768-774.
5. Maruyama R, Aoki F, Toyota M, Sasaki Y, Akashi H, Mita H, Suzuki H,
Akino K, Ohe-Toyota M, Maruyama Y, et al.:  Comparative
genome analysis identifies the vitamin D receptor gene as a
direct target of p53-mediated transcriptional activation.
Cancer Res 2006, 66:4574-4583.
6. Yan J, Yu CT, Ozen M, Ittmann M, Tsai SY, Tsai MJ: Steroid recep-
tor coactivator-3 and activator protein-1 coordinately regu-
late the transcription of components of the insulin-like
growth factor/AKT signaling pathway.  Cancer Res 2006,
66:11039-11046.
7. Britsch S, Goerich DE, Riethmacher D, Peirano RI, Rossner M, Nave
KA, Birchmeier C, Wegner M: The transcription factor Sox10 is
a key regulator of peripheral glial development.  Genes Dev
2001, 15:66-78.
8. Kim J, Lo L, Dormand E, Anderson DJ: SOX10 maintains multipo-
tency and inhibits neuronal differentiation of neural crest
stem cells.  Neuron 2003, 38:17-31.
9. Kuhlbrodt K, Herbarth B, Sock E, Hermans-Borgmeyer I, Wegner M:
Sox10, a novel transcriptional modulator in glial cells.  J Neu-
rosci 1998, 18:237-250.
10. Kelsh RN: Sorting out Sox10 functions in neural crest devel-
opment.  Bioessays 2006, 28:788-798.
Additional file 1
Genes down-regulated by Sox10 specific siRNA. The 88 probe sets/genes 
that show more than 4 fold down-regulation by wild type Sox10 siRNA. 
44 genes in bold letters with RefSeq ID were subsequently subjected to 
comparative genomics analysis.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-408-S1.doc]
Additional file 2
Candidate Sox10 protein binding sites. The 95 conserved putative SOX10 
binding sites. The location of each site on rat chromosome is indicated and 
linked to UCSC genome browser.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-408-S2.doc]
Additional file 3
Oligonucleotide primers used for ChIP assay. List and sequence of oligo-
nucleotide primers used for ChIP assay.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-408-S3.doc]
Additional file 4
Oligonucleotide primers used for RT-PCR. List and sequence of oligonu-
cleotide primers used for RT-PCRassay.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-408-S4.doc]Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Genomics 2008, 9:408 http://www.biomedcentral.com/1471-2164/9/408
Page 10 of 10
(page number not for citation purposes)
11. Paratore C, Eichenberger C, Suter U, Sommer L: Sox10 haploinsuf-
ficiency affects maintenance of progenitor cells in a mouse
model of Hirschsprung disease.  Hum Mol Genet 2002,
11:3075-3085.
12. Southard-Smith EM, Kos L, Pavan WJ: Sox10 mutation disrupts
neural crest development in Dom Hirschsprung mouse
model.  Nat Genet 1998, 18:60-64.
13. Pingault V, Bondurand N, Kuhlbrodt K, Goerich DE, Prehu MO, Puliti
A, Herbarth B, Hermans-Borgmeyer I, Legius E, Matthijs G, et al.:
SOX10 mutations in patients with Waardenburg-Hirschs-
prung disease.  Nat Genet 1998, 18:171-173.
14. Bondurand N, Girard M, Pingault V, Lemort N, Dubourg O, Goossens
M: Human Connexin 32, a gap junction protein altered in the
X-linked form of Charcot-Marie-Tooth disease, is directly
regulated by the transcription factor SOX10.  Hum Mol Genet
2001, 10:2783-2795.
15. Ito Y, Wiese S, Funk N, Chittka A, Rossoll W, Bommel H, Watabe K,
Wegner M, Sendtner M: Sox10 regulates ciliary neurotrophic
factor gene expression in Schwann cells.  Proc Natl Acad Sci USA
2006, 103:7871-7876.
16. Peirano RI, Goerich DE, Riethmacher D, Wegner M: Protein zero
gene expression is regulated by the glial transcription factor
Sox10.  Mol Cell Biol 2000, 20:3198-3209.
17. Wei Q, Miskimins WK, Miskimins R: Sox10 acts as a tissue-spe-
cific transcription factor enhancing activation of the myelin
basic protein gene promoter by p27Kip1 and Sp1.  J Neurosci
Res 2004, 78:796-802.
18. Jiao Z, Mollaaghababa R, Pavan WJ, Antonellis A, Green ED, Hornyak
TJ: Direct interaction of Sox10 with the promoter of murine
Dopachrome Tautomerase (Dct) and synergistic activation
of Dct expression with Mitf.  Pigment Cell Res 2004, 17:352-362.
19. Lee M, Goodall J, Verastegui C, Ballotti R, Goding CR: Direct regu-
lation of the Microphthalmia promoter by Sox10 links
Waardenburg-Shah syndrome (WS4)-associated hypopig-
mentation and deafness to WS2.  J Biol Chem 2000,
275:37978-37983.
20. Potterf SB, Furumura M, Dunn KJ, Arnheiter H, Pavan WJ: Tran-
scription factor hierarchy in Waardenburg syndrome: regu-
lation of MITF expression by SOX10 and PAX3.  Hum Genet
2000, 107:1-6.
21. Roh J, Cho EA, Seong I, Limb JK, Lee S, Han SJ, Kim J: Down-regu-
lation of Sox10 with specific small interfering RNA promotes
transdifferentiation of Schwannoma cells into myofibrob-
lasts.  Differentiation 2006, 74:542-551.
22. Denny P, Swift S, Connor F, Ashworth A: An SRY-related gene
expressed during spermatogenesis in the mouse encodes a
sequence-specific DNA-binding protein.  Embo J 1992,
11:3705-3712.
23. Harley VR, Lovell-Badge R, Goodfellow PN: Definition of a consen-
sus DNA binding site for SRY.  Nucleic Acids Res 1994,
22:1500-1501.
24. Kanai Y, Kanai-Azuma M, Noce T, Saido TC, Shiroishi T, Hayashi Y,
Yazaki K: Identification of two Sox17 messenger RNA iso-
forms, with and without the high mobility group box region,
and their differential expression in mouse spermatogenesis.
J Cell Biol 1996, 133:667-681.
25. Mertin S, McDowall SG, Harley VR: The DNA-binding specificity
of SOX9 and other SOX proteins.  Nucleic Acids Res 1999,
27:1359-1364.
26. Stolt CC, Rehberg S, Ader M, Lommes P, Riethmacher D, Schachner
M, Bartsch U, Wegner M: Terminal differentiation of myelin-
forming oligodendrocytes depends on the transcription fac-
tor Sox10.  Genes Dev 2002, 16:165-170.
27. Shy ME, Hobson G, Jain M, Boespflug-Tanguy O, Garbern J, Sperle K,
Li W, Gow A, Rodriguez D, Bertini E, et al.: Schwann cell expres-
sion of PLP1 but not DM20 is necessary to prevent neuropa-
thy.  Ann Neurol 2003, 53:354-365.
28. Wight PA, Duchala CS, Shick HE, Gudz TI, Macklin WB: Expression
of a myelin proteolipid protein (Plp)-lacZ transgene is
reduced in both the CNS and PNS of Plp(jp) mice.  Neurochem
Res 2007, 32:343-351.
29. Deuel TF, Zhang N, Yeh HJ, Silos-Santiago I, Wang ZY: Pleio-
trophin: a cytokine with diverse functions and a novel signal-
ing pathway.  Arch Biochem Biophys 2002, 397:162-171.
30. Wanaka A, Carroll SL, Milbrandt J: Developmentally regulated
expression of pleiotrophin, a novel heparin binding growth
factor, in the nervous system of the rat.  Brain Res Dev Brain Res
1993, 72:133-144.
31. Mi R, Chen W, Hoke A: Pleiotrophin is a neurotrophic factor
for spinal motor neurons.  Proc Natl Acad Sci USA 2007,
104:4664-4669.
32. Carlsson LM, Jonsson J, Edlund T, Marklund SL: Mice lacking extra-
cellular superoxide dismutase are more sensitive to hyper-
oxia.  Proc Natl Acad Sci USA 1995, 92:6264-6268.
33. Hu D, Serrano F, Oury TD, Klann E: Aging-dependent alterations
in synaptic plasticity and memory in mice that overexpress
extracellular superoxide dismutase.  J Neurosci 2006,
26:3933-3941.
34. Qi X, Hauswirth WW, Guy J: Dual gene therapy with extracel-
lular superoxide dismutase and catalase attenuates experi-
mental optic neuritis.  Mol Vis 2007, 13:1-11.
35. Kel AE, Gossling E, Reuter I, Cheremushkin E, Kel-Margoulis OV,
Wingender E: MATCH: A tool for searching transcription fac-
tor binding sites in DNA sequences.  Nucleic Acids Res 2003,
31:3576-3579.
36. Matys V, Kel-Margoulis OV, Fricke E, Liebich I, Land S, Barre-Dirrie
A, Reuter I, Chekmenev D, Krull M, Hornischer K, et al.: TRANS-
FAC and its module TRANSCompel: transcriptional gene
regulation in eukaryotes.  Nucleic Acids Res 2006, 34:D108-110.
37. Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, Rosenbloom
K, Clawson H, Spieth J, Hillier LW, Richards S, et al.: Evolutionarily
conserved elements in vertebrate, insect, worm, and yeast
genomes.  Genome Res 2005, 15:1034-1050.
38. Hinrichs AS, Karolchik D, Baertsch R, Barber GP, Bejerano G, Claw-
son H, Diekhans M, Furey TS, Harte RA, Hsu F, et al.: The UCSC
Genome Browser Database: update 2006.  Nucleic Acids Res
2006, 34:D590-598.